Device Trial Radar · NCT06294795
Toric Intraocular Lens Implantation in Pediatric Cataract
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Mar 1, 2024
Primary completion
Feb 5, 2025
Study completion Mar 16, 2026
Sponsor
- Lead sponsor
- Kazakh Eye Research InstituteResearch network
- Sponsor type
- Research network
- First posted
- Mar 6, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 6 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the visual and refractive outcomes after an intraocular lens (IOL) implantation in pediatric eyes with cataract and preexisting corneal astigmatism
Conditions
- Cataract Congenital
- Astigmatism
- IOL
Interventions
congenital/pediatric cataract surgeryProcedure
All procedures are performed under general anesthesia according to the standard technique of congenital/pediatric cataract surgery with an intraocular lens (IOL) implantation. Paracentesis is performed at 2.30 o\'clock using a 20-gauge straight microvitreoretinal (MVR) knife; a high molecular weight ophthalmic viscosurgical devices (OVD) is injected into the anterior chamber. Then a 2.4 mm corneal tunnel incision is made at 11 o'clock with a disposable keratome knife 2.2 mm. Circular continuous capsulorhexis (≈ 5.5 mm). Сortical cleaving hydrodissection is followed by bimanual phacoaspiration in irrigation-aspiration mode. OVD is injected in the anterior chamber and an IOL is implanted in the capsular bag. Residual OVD is aspirated from the anterior chamber and behind the IOL and followed by IOL alignment. The surgery is completed with corneal hydration at the tunnel incision site.
Non-Toric IOLsDevice
A folding hydrophobic acrylic IOLs AcrySof IQ SN60WF and Clareon SY60WF for the non-toric group (Alcon Laboratories, Inc.) ARE implanted.
Toric IOLsDevice
A folding hydrophobic acrylic IOLs AcrySof IQ Toric SN6ATx and Clareon Toric CNW0Tx for the toric group (Alcon Laboratories, Inc.) were implanted.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Uncorrected (UCDVA) and corrected (CDVA) distance visual acuityTime frame: recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)
- Uncorrected (UCNVA) and corrected (CNVA) near visual acuityTime frame: recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)
- Refraction measurementsTime frame: recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Kazakh Eye Research Institute
Almaty, Kazakhstan
Kazakh Eye Research Institute
Astana, Kazakhstan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.